4.6 Review

The role of CKIP-1 in osteoporosis development and treatment

期刊

BONE & JOINT RESEARCH
卷 7, 期 2, 页码 173-178

出版社

BRITISH EDITORIAL SOC BONE JOINT SURGERY
DOI: 10.1302/2046-3758.72.BJR-2017-0172.R1

关键词

Osteoporosis; CKIP-1; Bone formation; BMP pathway

资金

  1. Research Grants Council of the Hong Kong Special Administrative Region, China [14119115, 14160917, 9054014 N_CityU102/15, T13-402/17-N]
  2. National Natural Science Foundation of China [81371946, 81430049, 81772322]
  3. Hong Kong Innovation Technology Commission Funds [ITS/UIM-305]
  4. Shenzhen Science and Technology Innovation Council of China [JCYJ20150630165236960, JSGG20160229195900623, JCYJ20150402152005636]
  5. Sanming Project of medicine in Shenzhen [SZSM20150602]

向作者/读者索取更多资源

Osteoporosis is a systemic skeletal disorder characterized by reduced bone mass and deterioration of bone microarchitecture, which results in increased bone fragility and fracture risk. Casein kinase 2-interacting protein-1 (CKIP-1) is a protein that plays an important role in regulation of bone formation. The effect of CKIP-1 on bone formation is mainly mediated through negative regulation of the bone morphogenetic protein pathway. In addition, CKIP-1 has an important role in the progression of osteoporosis. This review provides a summary of the recent studies on the role of CKIP-1 in osteoporosis development and treatment.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据